Using patents published by leading pharmaceutical companies in the 2000–2010 period, the molecular properties of the compounds acting at the drug targets pursued have been analysed. Over the past ...
In September’s SLAS Discovery cover article, “Using Physicochemical Measurements to Influence Better Compound Design,” authors Robert J. Young, Ph.D., Shenaz B ...
Design Hub is the all-in-one DMTA platform that effectively manages drug design projects from idea creation to implementation. Built to connect medicinal chemistry teams, Chemaxon’s Design Hub allows ...
Optibrium, a leading developer of software and AI solutions for molecular design, today announced the release of StarDrop 8, the most significant update to its comprehensive discovery platform in its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results